Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma
Clinical trial NCT02195180 · COMPLETED
Trial details
- NCT number
- NCT02195180
- Sponsor
- ERYtech Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2017-02-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.